Prescribing drugs of dependence in general practice

Part C1 - Opioids

Figures and tables

Last revised: 14 Apr 2020

Guideline chapter figures and tables

Figures and tables from each chapter are available to view or download below.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day

Figure 1.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day
 Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by drug

Figure 2.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by drug
 Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by age group

Figure 3.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by age group
Rate of opioid* hospital separations for poisoning, per million persons, 2001 to 2011

Figure 4.

Rate of opioid* hospital separations for poisoning, per million persons, 2001 to 201112
 Annual frequency of overdose deaths involving most frequent contributing individual drugs, Victoria 2009–16

Table 1.

Annual frequency of overdose deaths involving most frequent contributing individual drugs, Victoria 2009–1618
Opioid prescribing in Australia: Definitions of drug dependence, state and territory authority requirements* and prescription rules

Table 2

Opioid prescribing in Australia: Definitions of drug dependence, state and territory authority requirements* and prescription rules
Table 3.

Table 3.

Patient risk groups46
 Patient groups that require caution when considering opioid therapy

Table 4.

Patient groups that require caution when considering opioid therapy53
Table 5.

Table 5.

State and territory legislative frameworks and clinical advisory services
Identifying patient risk

Table 6.

Identifying patient risk

Advertising